[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Durvalumab Market Status, Trends and COVID-19 Impact Report 2021

March 2022 | 117 pages | ID: GF0BC0133985EN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Durvalumab market experienced a huge change under the influence of COVID-19, the global market size of Durvalumab reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of XXX from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Durvalumab market and global economic environment, we forecast that the global market size of Durvalumab will reach (2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Durvalumab Market Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global Durvalumab market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-2021E, this report also provide forecast data from 2021-2026.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Medimmune (AstraZeneca)

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
2.4mL Injection
10mL Injection

Application Segmentation
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2021-2026)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source

SECTION 1 DURVALUMAB MARKET OVERVIEW

1.1 Durvalumab Market Scope
1.2 COVID-19 Impact on Durvalumab Market
1.3 Global Durvalumab Market Status and Forecast Overview
  1.3.1 Global Durvalumab Market Status 2016-2021
  1.3.2 Global Durvalumab Market Forecast 2021-2026

SECTION 2 GLOBAL DURVALUMAB MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Durvalumab Sales Volume
2.2 Global Manufacturer Durvalumab Business Revenue

SECTION 3 MANUFACTURER DURVALUMAB BUSINESS INTRODUCTION

3.1 Medimmune (AstraZeneca) Durvalumab Business Introduction
  3.1.1 Medimmune (AstraZeneca) Durvalumab Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.1.2 Medimmune (AstraZeneca) Durvalumab Business Distribution by Region
  3.1.3 Medimmune (AstraZeneca) Interview Record
  3.1.4 Medimmune (AstraZeneca) Durvalumab Business Profile
  3.1.5 Medimmune (AstraZeneca) Durvalumab Product Specification
  3.2.3 Interview Record
3.3 Manufacturer three Durvalumab Business Introduction
  3.3.1 Manufacturer three Durvalumab Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.3.2 Manufacturer three Durvalumab Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Durvalumab Business Overview
  3.3.5 Manufacturer three Durvalumab Product Specification

SECTION 4 GLOBAL DURVALUMAB MARKET SEGMENTATION (BY REGION)

4.1 North America Country
  4.1.1 United States Durvalumab Market Size and Price Analysis 2016-2021
  4.1.2 Canada Durvalumab Market Size and Price Analysis 2016-2021
  4.1.3 Mexico Durvalumab Market Size and Price Analysis 2016-2021
4.2 South America Country
  4.2.1 Brazil Durvalumab Market Size and Price Analysis 2016-2021
  4.2.2 Argentina Durvalumab Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
  4.3.1 China Durvalumab Market Size and Price Analysis 2016-2021
  4.3.2 Japan Durvalumab Market Size and Price Analysis 2016-2021
  4.3.3 India Durvalumab Market Size and Price Analysis 2016-2021
  4.3.4 Korea Durvalumab Market Size and Price Analysis 2016-2021
  4.3.5 Southeast Asia Durvalumab Market Size and Price Analysis 2016-2021
4.4 Europe Country
  4.4.1 Germany Durvalumab Market Size and Price Analysis 2016-2021
  4.4.2 UK Durvalumab Market Size and Price Analysis 2016-2021
  4.4.3 France Durvalumab Market Size and Price Analysis 2016-2021
  4.4.4 Spain Durvalumab Market Size and Price Analysis 2016-2021
  4.4.5 Italy Durvalumab Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
  4.5.1 Africa Durvalumab Market Size and Price Analysis 2016-2021
  4.5.2 Middle East Durvalumab Market Size and Price Analysis 2016-2021
4.6 Global Durvalumab Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Durvalumab Market Segmentation (By Region) Analysis

SECTION 5 GLOBAL DURVALUMAB MARKET SEGMENTATION (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 2.4mL Injection Product Introduction
  5.1.2 10mL Injection Product Introduction
5.2 Global Durvalumab Sales Volume by 10mL Injection016-2021
5.3 Global Durvalumab Market Size by 10mL Injection016-2021
5.4 Different Durvalumab Product Type Price 2016-2021
5.5 Global Durvalumab Market Segmentation (By Type) Analysis

SECTION 6 GLOBAL DURVALUMAB MARKET SEGMENTATION (BY APPLICATION)

6.1 Global Durvalumab Sales Volume by Application 2016-2021
6.2 Global Durvalumab Market Size by Application 2016-2021
6.2 Durvalumab Price in Different Application Field 2016-2021
6.3 Global Durvalumab Market Segmentation (By Application) Analysis

SECTION 7 GLOBAL DURVALUMAB MARKET SEGMENTATION (BY CHANNEL)

7.1 Global Durvalumab Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Durvalumab Market Segmentation (By Channel) Analysis

SECTION 8 DURVALUMAB MARKET FORECAST 2021-2026

8.1 Durvalumab Segmentation Market Forecast 2021-2026 (By Region)
8.2 Durvalumab Segmentation Market Forecast 2021-2026 (By Type)
8.3 Durvalumab Segmentation Market Forecast 2021-2026 (By Application)
8.4 Durvalumab Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Durvalumab Price Forecast

SECTION 9 DURVALUMAB APPLICATION AND CLIENT ANALYSIS

9.1 Locally Advanced Urothelial Carcinoma Customers
9.2 Metastatic Urothelial Carcinoma Customers

SECTION 10 DURVALUMAB MANUFACTURING COST OF ANALYSIS

11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

SECTION 11 CONCLUSION

SECTION 12 METHODOLOGY AND DATA SOURCE

CHART AND FIGURE

Figure Durvalumab Product Picture
Chart Global Durvalumab Market Size (with or without the impact of COVID-19)
Chart Global Durvalumab Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Durvalumab Market Size (Million $) and Growth Rate 2016-2021
Chart Global Durvalumab Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Durvalumab Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Durvalumab Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Durvalumab Sales Volume Share
Chart 2016-2021 Global Manufacturer Durvalumab Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Durvalumab Business Revenue Share
Chart Medimmune (AstraZeneca) Durvalumab Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Medimmune (AstraZeneca) Durvalumab Business Distribution
Chart Medimmune (AstraZeneca) Interview Record (Partly)
Chart Medimmune (AstraZeneca) Durvalumab Business Profile
Table Medimmune (AstraZeneca) Durvalumab Product Specification
Chart United States Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Canada Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Mexico Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Brazil Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Argentina Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Durvalumab Sales Price (USD/Unit) 2016-2021
Chart China Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Japan Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Durvalumab Sales Price (USD/Unit) 2016-2021
Chart India Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Korea Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Germany Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Durvalumab Sales Price (USD/Unit) 2016-2021
Chart UK Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Durvalumab Sales Price (USD/Unit) 2016-2021
Chart France Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Spain Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Italy Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Africa Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Middle East Durvalumab Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Durvalumab Sales Price (USD/Unit) 2016-2021
Chart Global Durvalumab Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Durvalumab Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Durvalumab Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Durvalumab Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart 2.4mL Injection Product Figure
Chart 2.4mL Injection Product Description
Chart 10mL Injection Product Figure
Chart 10mL Injection Product Description
Chart Durvalumab Sales Volume (Units) by 10mL Injection016-2021
Chart Durvalumab Sales Volume (Units) Share by Type
Chart Durvalumab Market Size (Million $) by 10mL Injection016-2021
Chart Durvalumab Market Size (Million $) Share by 10mL Injection016-2021
Chart Different Durvalumab Product Type Price ($/Unit) 2016-2021
Chart Durvalumab Sales Volume (Units) by Application 2016-2021
Chart Durvalumab Sales Volume (Units) Share by Application
Chart Durvalumab Market Size (Million $) by Application 2016-2021
Chart Durvalumab Market Size (Million $) Share by Application 2016-2021
Chart Durvalumab Price in Different Application Field 2016-2021
Chart Global Durvalumab Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Durvalumab Market Segmentation (By Channel) Share 2016-2021
Chart Durvalumab Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Durvalumab Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Durvalumab Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Durvalumab Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Durvalumab Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Durvalumab Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Durvalumab Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Durvalumab Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Durvalumab Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Durvalumab Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Durvalumab Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Durvalumab Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Durvalumab Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Durvalumab Market Segmentation (By Channel) Share 2021-2026
Chart Global Durvalumab Price Forecast 2021-2026
Chart Locally Advanced Urothelial Carcinoma Customers
Chart Metastatic Urothelial Carcinoma Customers


More Publications